List of IPO Filings
Arrived Homes 3, LLC
View detailsFiling Date: January 30, 2025
Accession Number: 000196272325000004
Corporate Action: Ipo
Summary preview: Arrived Homes 3, LLC has filed an offering circular related to a best efforts offering of Series Mem...
Arrived Homes, LLC
View detailsFiling Date: January 30, 2025
Accession Number: 000182172025000004
Corporate Action: Ipo
Summary preview: Arrived Homes, LLC is conducting a best efforts offering of series membership interests in a unique ...
Arrived STR 2, LLC
View detailsFiling Date: January 30, 2025
Accession Number: 000196803925000004
Corporate Action: Ipo
Summary preview: Arrived STR 2, LLC is conducting a best efforts offering of Series Membership Interests to allow pub...
Arrived STR, LLC
View detailsFiling Date: January 30, 2025
Accession Number: 000194220825000004
Corporate Action: Ipo
Summary preview: Arrived STR, LLC is a Delaware series limited liability company that allows public investment in ind...
Atlas Energy Solutions Inc.
View detailsFiling Date: January 30, 2025
Accession Number: 000110465925007640
Corporate Action: Ipo
Summary preview: On January 30, 2025, Atlas Energy Solutions Inc. announced its intention to conduct an underwritten ...
Blackstone Private Credit Fund
View detailsFiling Date: January 30, 2025
Accession Number: 000119312525016793
Corporate Action: Ipo
Summary preview: Blackstone Private Credit Fund, a Delaware statutory trust, is engaging in a continuous public offer...
Butterfly Network, Inc.
View detailsFiling Date: January 30, 2025
Accession Number: 000110465925007629
Corporate Action: Ipo
Summary preview: On January 29, 2025, Butterfly Network, Inc. entered into an underwriting agreement with TD Securiti...
Elicio Therapeutics, Inc.
View detailsFiling Date: January 30, 2025
Accession Number: 000119312525016368
Corporate Action: Ipo
Summary preview: Elicio Therapeutics, Inc. is offering 1,261,830 shares of common stock alongside common warrants to ...
Hashdex Nasdaq Crypto Index US ETF
View detailsFiling Date: January 30, 2025
Accession Number: 000121390025008408
Corporate Action: Ipo
Summary preview: Hashdex Nasdaq Crypto Index US ETF is being registered to provide investors with price exposure to s...
HIGH WIRE NETWORKS, INC.
View detailsFiling Date: January 30, 2025
Accession Number: 000121390025008088
Corporate Action: Ipo
Summary preview: High Wire Networks, Inc. filed a Registration Statement under the Securities Act of 1933 on January ...
HINES GLOBAL INCOME TRUST, INC.
View detailsFiling Date: January 30, 2025
Accession Number: 000158510125000007
Corporate Action: Ipo
Summary preview: Hines Global Income Trust, Inc. (HGIT), a Maryland corporation, is amending its registration stateme...
Immunome Inc.
View detailsFiling Date: January 30, 2025
Accession Number: 000110465925007610
Corporate Action: Ipo
Summary preview: On January 29, 2025, Immunome, Inc. entered into an underwriting agreement with J.P. Morgan Securiti...
Filing Date: January 29, 2025
Accession Number: 000110465925007230
Corporate Action: Ipo
Summary preview: Immunome Inc. is conducting an offering of $125,000,000 worth of shares of common stock, trading und...
Filing Date: January 29, 2025
Accession Number: 000110465925007198
Corporate Action: Ipo
Summary preview: On January 29, 2025, Immunome Inc. announced the commencement of an underwritten public offering of ...
Inspira Technologies OXY B.H.N. Ltd
View detailsFiling Date: January 30, 2025
Accession Number: 000121390025008364
Corporate Action: Ipo
Summary preview: Inspira Technologies OXY B.H.N. Ltd is offering a resale of up to 9,217,430 Ordinary Shares through ...
Filing Date: January 22, 2025
Accession Number: 000121390025005430
Corporate Action: Ipo
Summary preview: Inspira Technologies OXY B.H.N. Ltd. submitted a request for the acceleration of the effective date ...
Filing Date: January 16, 2025
Accession Number: 000121390025004023
Corporate Action: Ipo
Summary preview: Inspira Technologies OXY B.H.N. Ltd has filed a Registration Statement on Form F-3 with the SEC, dat...
Sonnet BioTherapeutics Holdings, Inc.
View detailsFiling Date: January 30, 2025
Accession Number: 000149315225004302
Corporate Action: Ipo
Summary preview: On January 30, 2025, Sonnet BioTherapeutics Holdings, Inc. filed an amendment to its Form S-1 regist...
Filing Date: January 30, 2025
Accession Number: 000149315225004303
Corporate Action: Ipo
Summary preview: On January 30, 2025, Sonnet BioTherapeutics Holdings, Inc. filed an amendment to its registration st...
Filing Date: January 22, 2025
Accession Number: 000149315225003230
Corporate Action: Ipo
Summary preview: On January 22, 2025, Sonnet BioTherapeutics Holdings, Inc. filed an S-1 registration statement under...
Filing Date: January 22, 2025
Accession Number: 000149315225003232
Corporate Action: Ipo
Summary preview: Sonnet BioTherapeutics Holdings, Inc. filed a registration statement on Form S-1 with the SEC on Jan...
Sunrise Realty Trust, Inc.
View detailsFiling Date: January 30, 2025
Accession Number: 000182912625000569
Corporate Action: Ipo
Summary preview: This Amendment No. 1 to Schedule 13D updates the previous filing originally made on December 26, 202...
Filing Date: January 29, 2025
Accession Number: 000162828025003000
Corporate Action: Ipo
Summary preview: On January 28, 2025, Sunrise Realty Trust, Inc. announced the pricing of an upsized underwritten off...
Filing Date: January 28, 2025
Accession Number: 000162828025002839
Corporate Action: Ipo
Summary preview: Sunrise Realty Trust, Inc. is offering 5,750,000 shares of its common stock at a public offering pri...
Filing Date: January 27, 2025
Accession Number: 000162828025002725
Corporate Action: Ipo
Summary preview: Sunrise Realty Trust, Inc. is filing a Registration Statement on Form S-11 with the SEC to register ...
Filing Date: January 24, 2025
Accession Number: 000162828025002543
Corporate Action: Ipo
Summary preview: Sunrise Realty Trust, Inc. has formally withdrawn its request for acceleration of the effective date...
89bio, Inc.
View detailsFiling Date: January 29, 2025
Accession Number: 000119312525015668
Corporate Action: Ipo
Summary preview: 89bio, Inc. is offering 21,671,428 shares of common stock at a public offering price of $8.75 per sh...
Filing Date: January 29, 2025
Accession Number: 000119312525015901
Corporate Action: Ipo
Summary preview: On January 28, 2025, 89bio, Inc. entered into an underwriting agreement to issue and sell 21,671,428...
Filing Date: January 27, 2025
Accession Number: 000119312525013470
Corporate Action: Ipo
Summary preview: On January 27, 2025, 89bio, Inc. filed a preliminary prospectus supplement related to an initial pub...
A2Z CUST2MATE SOLUTIONS CORP.
View detailsFiling Date: January 29, 2025
Accession Number: 000149315225004081
Corporate Action: Ipo
Summary preview: A2Z Cust2Mate Solutions Corp. is offering 3,281,250 common shares at a public offering price of $6.4...
Filing Date: January 27, 2025
Accession Number: 000149315225003790
Corporate Action: Ipo
Summary preview: A2Z Cust2Mate Solutions Corp. is conducting an initial public offering (IPO) of its common shares wi...
AIP Alternative Lending Fund A
View detailsFiling Date: January 29, 2025
Accession Number: 000113322825000652
Corporate Action: Ipo
Summary preview: AIP Alternative Lending Fund A has filed a registration statement under the Securities Act of 1933 a...
AIP Alternative Lending Fund P
View detailsFiling Date: January 29, 2025
Accession Number: 000113322825000739
Corporate Action: Ipo
Summary preview: The AIP Alternative Lending Fund P filed a registration statement under the Securities Act of 1933 a...
C2 Blockchain,Inc.
View detailsFiling Date: January 29, 2025
Accession Number: 000188278125000010
Corporate Action: Ipo
Summary preview: C2 Blockchain, Inc. filed Offering Circular Supplement No. 1 on January 29, 2025, to update its prev...
Kairos Pharma, LTD.
View detailsFiling Date: January 29, 2025
Accession Number: 000149315225004041
Corporate Action: Ipo
Summary preview: Kairos Pharma, Ltd. is filing a Form S-1 registration statement with the SEC to offer up to 6,425,00...
Lichen China Ltd
View detailsFiling Date: January 29, 2025
Accession Number: 000121390025007741
Corporate Action: Ipo
Summary preview: Lichen China Ltd is offering a total of 20,933,333 Class A Ordinary Shares and Pre-Funded Warrants t...
Filing Date: December 31, 2024
Accession Number: 000121390024113691
Corporate Action: Ipo
Summary preview: Lichen China Limited, a Cayman Islands holding company, is offering 13,200,000 Class A ordinary shar...
Filing Date: December 27, 2024
Accession Number: 000121390024112978
Corporate Action: Ipo
Summary preview: Lichen China Limited is offering an aggregate of 10,433,333 Class A Ordinary Shares and pre-funded w...
M2i Global, Inc.
View detailsFiling Date: January 29, 2025
Accession Number: 000149315225004088
Corporate Action: Ipo
Summary preview: M2i Global, Inc. is conducting a public offering of up to 138,888,888 shares of its common stock at ...
Filing Date: January 24, 2025
Accession Number: 000149315225003593
Corporate Action: Ipo
Summary preview: M2i Global, Inc. is proceeding with its Offering Statement on Form 1-A, which was initially filed on...
McQueen Labs Series, LLC
View detailsFiling Date: January 29, 2025
Accession Number: 000149315225004113
Corporate Action: Ipo
Summary preview: McQueen Labs Series, LLC is conducting its first offering of Class A Units representing Class A limi...
Processa Pharmaceuticals, Inc.
View detailsFiling Date: January 29, 2025
Accession Number: 000149315225004111
Corporate Action: Ipo
Summary preview: Processa Pharmaceuticals, Inc. is conducting a public offering of 1,030,972 shares of common stock a...
Filing Date: January 27, 2025
Accession Number: 000149315225003730
Corporate Action: Ipo
Summary preview: Processa Pharmaceuticals, Inc. submitted a correspondence to the United States Securities and Exchan...
Filing Date: January 27, 2025
Accession Number: 000149315225003731
Corporate Action: Ipo
Summary preview: Processa Pharmaceuticals, Inc. is requesting the U.S. Securities and Exchange Commission to take act...
Filing Date: January 27, 2025
Accession Number: 000149315225003720
Corporate Action: Ipo
Summary preview: Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, filed its amendment to F...
Filing Date: January 17, 2025
Accession Number: 000149315225002809
Corporate Action: Ipo
Summary preview: Processa Pharmaceuticals, Inc. is requesting the Securities and Exchange Commission to take action t...
REZOLVE AI Ltd
View detailsFiling Date: January 29, 2025
Accession Number: 000095017025010107
Corporate Action: Ipo
Summary preview: On January 29, 2025, Rezolve AI Ltd filed an amended registration statement regarding its IPO. The d...
Filing Date: January 13, 2025
Accession Number: 000095017025004476
Corporate Action: Ipo
Summary preview: REZOLVE AI Ltd has filed a Registration Statement on Form F-1, indicating its plans for an Initial P...
Filing Date: December 18, 2024
Accession Number: 000095017024137968
Corporate Action: Ipo
Summary preview: Rezolve AI Limited has filed a request for the acceleration of the effective date of its Registratio...
SELLAS Life Sciences Group, Inc.
View detailsFiling Date: January 29, 2025
Accession Number: 000110465925007097
Corporate Action: Ipo
Summary preview: SELLAS Life Sciences Group, Inc. is offering a total of 8,200,000 shares of its common stock along w...